The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global CAR-T Cellular Immunotherapy Drug Market Research Report 2025
Synopsis
The global CAR-T Cellular Immunotherapy Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for CAR-T Cellular Immunotherapy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cellular Immunotherapy Drug.
Report Scope
The CAR-T Cellular Immunotherapy Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CAR-T Cellular Immunotherapy Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Cellular Immunotherapy Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Kite Pharma
Bristol Myers Squibb
Fosun Pharma
Segment by Type
CD19-Targeted
BCMA-Targeted
Segment by Application
Multiple Myeloma
Non-Hodgkin lymphoma
Leukemia
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Cellular Immunotherapy Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global CAR-T Cellular Immunotherapy Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for CAR-T Cellular Immunotherapy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cellular Immunotherapy Drug.
Report Scope
The CAR-T Cellular Immunotherapy Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CAR-T Cellular Immunotherapy Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Cellular Immunotherapy Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Kite Pharma
Bristol Myers Squibb
Fosun Pharma
Segment by Type
CD19-Targeted
BCMA-Targeted
Segment by Application
Multiple Myeloma
Non-Hodgkin lymphoma
Leukemia
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Cellular Immunotherapy Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CD19-Targeted
1.2.3 BCMA-Targeted
1.3 Market by Application
1.3.1 Global CAR-T Cellular Immunotherapy Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Multiple Myeloma
1.3.3 Non-Hodgkin lymphoma
1.3.4 Leukemia
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Cellular Immunotherapy Drug Market Perspective (2019-2030)
2.2 CAR-T Cellular Immunotherapy Drug Growth Trends by Region
2.2.1 Global CAR-T Cellular Immunotherapy Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CAR-T Cellular Immunotherapy Drug Historic Market Size by Region (2019-2024)
2.2.3 CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Region (2025-2030)
2.3 CAR-T Cellular Immunotherapy Drug Market Dynamics
2.3.1 CAR-T Cellular Immunotherapy Drug Industry Trends
2.3.2 CAR-T Cellular Immunotherapy Drug Market Drivers
2.3.3 CAR-T Cellular Immunotherapy Drug Market Challenges
2.3.4 CAR-T Cellular Immunotherapy Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-T Cellular Immunotherapy Drug Players by Revenue
3.1.1 Global Top CAR-T Cellular Immunotherapy Drug Players by Revenue (2019-2024)
3.1.2 Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Players (2019-2024)
3.2 Global CAR-T Cellular Immunotherapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR-T Cellular Immunotherapy Drug Revenue
3.4 Global CAR-T Cellular Immunotherapy Drug Market Concentration Ratio
3.4.1 Global CAR-T Cellular Immunotherapy Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Cellular Immunotherapy Drug Revenue in 2023
3.5 CAR-T Cellular Immunotherapy Drug Key Players Head office and Area Served
3.6 Key Players CAR-T Cellular Immunotherapy Drug Product Solution and Service
3.7 Date of Enter into CAR-T Cellular Immunotherapy Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T Cellular Immunotherapy Drug Breakdown Data by Type
4.1 Global CAR-T Cellular Immunotherapy Drug Historic Market Size by Type (2019-2024)
4.2 Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Type (2025-2030)
5 CAR-T Cellular Immunotherapy Drug Breakdown Data by Application
5.1 Global CAR-T Cellular Immunotherapy Drug Historic Market Size by Application (2019-2024)
5.2 Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CAR-T Cellular Immunotherapy Drug Market Size (2019-2030)
6.2 North America CAR-T Cellular Immunotherapy Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2019-2024)
6.4 North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-T Cellular Immunotherapy Drug Market Size (2019-2030)
7.2 Europe CAR-T Cellular Immunotherapy Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2019-2024)
7.4 Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size (2019-2030)
8.2 Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR-T Cellular Immunotherapy Drug Market Size (2019-2030)
9.2 Latin America CAR-T Cellular Immunotherapy Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2019-2024)
9.4 Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size (2019-2030)
10.2 Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG CAR-T Cellular Immunotherapy Drug Introduction
11.1.4 Novartis AG Revenue in CAR-T Cellular Immunotherapy Drug Business (2019-2024)
11.1.5 Novartis AG Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Company Detail
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma CAR-T Cellular Immunotherapy Drug Introduction
11.2.4 Kite Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2019-2024)
11.2.5 Kite Pharma Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Detail
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Introduction
11.3.4 Bristol Myers Squibb Revenue in CAR-T Cellular Immunotherapy Drug Business (2019-2024)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Fosun Pharma
11.4.1 Fosun Pharma Company Detail
11.4.2 Fosun Pharma Business Overview
11.4.3 Fosun Pharma CAR-T Cellular Immunotherapy Drug Introduction
11.4.4 Fosun Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2019-2024)
11.4.5 Fosun Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of CD19-Targeted
Table 3. Key Players of BCMA-Targeted
Table 4. Global CAR-T Cellular Immunotherapy Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global CAR-T Cellular Immunotherapy Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global CAR-T Cellular Immunotherapy Drug Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global CAR-T Cellular Immunotherapy Drug Market Share by Region (2019-2024)
Table 8. Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global CAR-T Cellular Immunotherapy Drug Market Share by Region (2025-2030)
Table 10. CAR-T Cellular Immunotherapy Drug Market Trends
Table 11. CAR-T Cellular Immunotherapy Drug Market Drivers
Table 12. CAR-T Cellular Immunotherapy Drug Market Challenges
Table 13. CAR-T Cellular Immunotherapy Drug Market Restraints
Table 14. Global CAR-T Cellular Immunotherapy Drug Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global CAR-T Cellular Immunotherapy Drug Market Share by Players (2019-2024)
Table 16. Global Top CAR-T Cellular Immunotherapy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cellular Immunotherapy Drug as of 2023)
Table 17. Ranking of Global Top CAR-T Cellular Immunotherapy Drug Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by CAR-T Cellular Immunotherapy Drug Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CAR-T Cellular Immunotherapy Drug Product Solution and Service
Table 21. Date of Enter into CAR-T Cellular Immunotherapy Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR-T Cellular Immunotherapy Drug Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Type (2019-2024)
Table 25. Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Type (2025-2030)
Table 27. Global CAR-T Cellular Immunotherapy Drug Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Application (2019-2024)
Table 29. Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Application (2025-2030)
Table 31. North America CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Novartis AG Company Detail
Table 47. Novartis AG Business Overview
Table 48. Novartis AG CAR-T Cellular Immunotherapy Drug Product
Table 49. Novartis AG Revenue in CAR-T Cellular Immunotherapy Drug Business (2019-2024) & (US$ Million)
Table 50. Novartis AG Recent Development
Table 51. Kite Pharma Company Detail
Table 52. Kite Pharma Business Overview
Table 53. Kite Pharma CAR-T Cellular Immunotherapy Drug Product
Table 54. Kite Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2019-2024) & (US$ Million)
Table 55. Kite Pharma Recent Development
Table 56. Bristol Myers Squibb Company Detail
Table 57. Bristol Myers Squibb Business Overview
Table 58. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Product
Table 59. Bristol Myers Squibb Revenue in CAR-T Cellular Immunotherapy Drug Business (2019-2024) & (US$ Million)
Table 60. Bristol Myers Squibb Recent Development
Table 61. Fosun Pharma Company Detail
Table 62. Fosun Pharma Business Overview
Table 63. Fosun Pharma CAR-T Cellular Immunotherapy Drug Product
Table 64. Fosun Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2019-2024) & (US$ Million)
Table 65. Fosun Pharma Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR-T Cellular Immunotherapy Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global CAR-T Cellular Immunotherapy Drug Market Share by Type: 2023 VS 2030
Figure 3. CD19-Targeted Features
Figure 4. BCMA-Targeted Features
Figure 5. Global CAR-T Cellular Immunotherapy Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global CAR-T Cellular Immunotherapy Drug Market Share by Application: 2023 VS 2030
Figure 7. Multiple Myeloma Case Studies
Figure 8. Non-Hodgkin lymphoma Case Studies
Figure 9. Leukemia Case Studies
Figure 10. CAR-T Cellular Immunotherapy Drug Report Years Considered
Figure 11. Global CAR-T Cellular Immunotherapy Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global CAR-T Cellular Immunotherapy Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global CAR-T Cellular Immunotherapy Drug Market Share by Region: 2023 VS 2030
Figure 14. Global CAR-T Cellular Immunotherapy Drug Market Share by Players in 2023
Figure 15. Global Top CAR-T Cellular Immunotherapy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cellular Immunotherapy Drug as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by CAR-T Cellular Immunotherapy Drug Revenue in 2023
Figure 17. North America CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America CAR-T Cellular Immunotherapy Drug Market Share by Country (2019-2030)
Figure 19. United States CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe CAR-T Cellular Immunotherapy Drug Market Share by Country (2019-2030)
Figure 23. Germany CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Share by Region (2019-2030)
Figure 31. China CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America CAR-T Cellular Immunotherapy Drug Market Share by Country (2019-2030)
Figure 39. Mexico CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Share by Country (2019-2030)
Figure 43. Turkey CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Novartis AG Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2019-2024)
Figure 46. Kite Pharma Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2019-2024)
Figure 47. Bristol Myers Squibb Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2019-2024)
Figure 48. Fosun Pharma Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2019-2024)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
